176 related articles for article (PubMed ID: 23585914)
1. High expression of KIF26B in breast cancer associates with poor prognosis.
Wang Q; Zhao ZB; Wang G; Hui Z; Wang MH; Pan JF; Zheng H
PLoS One; 2013; 8(4):e61640. PubMed ID: 23585914
[TBL] [Abstract][Full Text] [Related]
2. Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.
Wang J; Cui F; Wang X; Xue Y; Chen J; Yu Y; Lu H; Zhang M; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Feb; 34(1):13. PubMed ID: 25652119
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
[TBL] [Abstract][Full Text] [Related]
4. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G
J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309
[TBL] [Abstract][Full Text] [Related]
5. KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer.
Wang J; Ma S; Ma R; Qu X; Liu W; Lv C; Zhao S; Gong Y
BMC Cancer; 2014 Jun; 14():461. PubMed ID: 24950762
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of ILK1 in breast cancer associates with poor prognosis.
Yang HJ; Zheng YB; Ji T; Ding XF; Zhu C; Yu XF; Ling ZQ
Tumour Biol; 2013 Dec; 34(6):3933-8. PubMed ID: 23832543
[TBL] [Abstract][Full Text] [Related]
7. ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer.
Wang S; Zhang H; Liu H; Guo X; Ma R; Zhu W; Gao P
Med Oncol; 2021 Nov; 39(1):15. PubMed ID: 34817735
[TBL] [Abstract][Full Text] [Related]
8. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
10. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
11. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
12. KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer.
Teng Y; Guo B; Mu X; Liu S
Biomed Pharmacother; 2018 Dec; 108():766-773. PubMed ID: 30248545
[TBL] [Abstract][Full Text] [Related]
13. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
[TBL] [Abstract][Full Text] [Related]
14. High expression of FOXR2 in breast cancer correlates with poor prognosis.
Song H; He W; Huang X; Zhang H; Huang T
Tumour Biol; 2016 May; 37(5):5991-7. PubMed ID: 26596836
[TBL] [Abstract][Full Text] [Related]
15. OLC1 is overexpressed in breast cancer and its expression correlates with poor patient survival.
Ou-Yang QH; Duan ZX; Jin Z; Lei JX
Tumour Biol; 2014 Sep; 35(9):8823-7. PubMed ID: 24880589
[TBL] [Abstract][Full Text] [Related]
16. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
Song GD; Sun Y; Shen H; Li W
Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
[TBL] [Abstract][Full Text] [Related]
17. Noncoding RNAs-based high KIF26B expression correlates with poor prognosis and tumor immune infiltration in colon cancer.
Liu Z; Zhou X; Chen B; Wu Z; Zhang C; Gu C; Li J; Yang X
Cell Cycle; 2023; 22(14-16):1726-1742. PubMed ID: 37436127
[TBL] [Abstract][Full Text] [Related]
18. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
[TBL] [Abstract][Full Text] [Related]
19. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
20. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
